The Clorox Company (CLX)
Debt-to-equity ratio
| Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-term debt | US$ in thousands | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Total stockholders’ equity | US$ in thousands | 27,000 | -41,000 | 60,000 | 328,000 | 91,000 | 53,000 | -37,000 | 220,000 | 3,000 | 321,000 | 326,000 | 556,000 | 400,000 | 313,000 | 368,000 | 411,000 | 743,000 | 1,184,000 | 1,115,000 | 908,000 |
| Debt-to-equity ratio | 0.00 | — | 0.00 | 0.00 | 0.00 | 0.00 | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
March 31, 2025 calculation
Debt-to-equity ratio = Long-term debt ÷ Total stockholders’ equity
= $—K ÷ $27,000K
= 0.00
The Clorox Company has consistently reported a debt-to-equity ratio of zero across multiple reporting periods, from June 30, 2020, through March 31, 2025, with minor gaps. This indicates that the company has maintained an entirely equity-financed capital structure, utilizing no significant long-term or short-term debt in its financial strategy during this timeframe. Such a financial profile suggests a conservative approach to leveraging, with the company relying solely on shareholders' equity to finance its operations and growth. The absence of reported debt implies that Clorox may prioritize financial stability and flexibility, potentially reducing financial risk associated with indebtedness. Overall, the unchanged zero debt-to-equity ratio points to a deliberately debt-free or near-debt-free capital structure over the analyzed period.